Siemens Healthineers (SHL.DE) stock: key figures, P/E, revenue and dividend
Health Care · Germany · ISIN DE000SHL1006
Siemens Healthineers financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 22.36 bn EUR | 23.38 bn EUR |
| Gross profit | 8.47 bn EUR | 9.03 bn EUR |
| Operating income | 2.81 bn EUR | 3.16 bn EUR |
| EBIT | 3.30 bn EUR | 3.44 bn EUR |
| Net income | 1.94 bn EUR | 2.14 bn EUR |
| Diluted EPS – continuing operations | 1.72 EUR | 1.91 EUR |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Siemens Healthineers
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
More stocks
- Ambev SA ADR (ABEV)
- Endesa SA (ELE.MC)
- Public Storage (PSA)
- E.ON (EOAN.DE)
- Edwards Lifesciences (EW)
- Workday, Inc. (WDAY)
- China Molybdenum Co Ltd Class A (603993.SS)
- Delta Air Lines (DAL)
- Marubeni Corp (8002.T)
- People's Insurance of China Ltd (601319.SS)
- Bayer (BAYN.DE)
- Honeywell Aerospace (HONA)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.